| |
PRODUCT NAME |
ORDER |
 |
8-Quinolinesulfonic acid, 5,7-dichloro- |
 |
 |
3-Pyridinol,6-(1-piperazinyl)-(9CI) |
 |
 |
1-(pyridin-2-yl)-1,4-diazepane |
 |
 |
1-(5-NITRO-2-PYRIDYL)-1,4-DIAZEPANE |
 |
 |
1H-1,2,4-Triazol-1-ylacetic acid |
 |
 |
2-Benzothiazolecarboxylicacid,6-fluoro-,ethylester(9CI) |
 |
 |
3,5-Cyclohexadiene-1,2-diol,3-methyl-6-(1-methylethyl)-,(1R,2S)-(9CI) |
 |
 |
1,3-Cyclohexadiene-1-acetonitrile, 5,6-dihydroxy-, (5S,6R)- (9CI) |
 |
 |
ETHYL 7-DIETHYLAMINO-COUMARIN-3-CARBOXYLATE |
 |
 |
CHRYSOPHENINE |
 |
 |
INDIGOTETRASULFONATE TETRAPOTASSIUM SALT |
 |
 |
CYCLODODECENE OXIDE |
 |
 |
8-Azabicyclo[3.2.1]oct-3-ene-6-carbonitrile,8-methyl-2-oxo-,(1R,5R,6S)-rel-(9CI) |
 |
 |
D(-)-Arabinose |
 |
 |
(R)-(+)-N-Boc-2-piperidinecarboxylic acid |
 |
 |
(L)-N-(BENZYLOXYCARBONYL)PIPECOLIC ACID |
 |
 |
(D)-N-Cbz-Pipecolic acid |
 |
 |
1-Propen-1-one, 2-(4-pyridinyl)- (9CI) |
 |
 |
1-Propen-1-one, 2-(3-pyridinyl)- (9CI) |
 |
 |
tert-butyl 4-(hydroxy((3-hydroxy-2,3-dimethylbutan-2-yl)oxy)boryl)-5,6-dihydropyridine-1(2H)-carboxylate |
 |
 |
2,5-Diazabicyclo[2.2.1]heptane,2-(3-pyridinyl)-,(1S,4S)-(9CI) |
 |
 |
Carbamic acid, (3-isothiocyanatopropyl)-, 1,1-dimethylethyl ester (9CI) |
 |
 |
Carbamic acid, [(1S)-1-(2-hydroxyethyl)-2-propenyl]-, 1,1-dimethylethyl ester |
 |
 |
2-(4-(Acetylamino)Phenyl)Propionitrile |
 |
 |
3,8-Diazabicyclo[3.2.1]octane,3-(3-pyridinyl)-(9CI) |
 |
 |
3,8-Diazabicyclo[3.2.1]octane,3-(3-pyridazinyl)-(9CI) |
 |
 |
2,5-Diazabicyclo[2.2.1]heptane,2-(3-pyridinylmethyl)-,(1R,4R)-(9CI) |
 |
 |
2,5-Diazabicyclo[2.2.2]octane,2-(3-pyridinyl)-,(1R,4R)-(9CI) |
 |
 |
2-Pyridinamine,5-(1R,4R)-2,5-diazabicyclo[2.2.1]hept-2-yl-(9CI) |
 |
 |
2,5-Diazabicyclo[2.2.1]heptane,2-(6-methyl-3-pyridinyl)-,(1R,4R)-(9CI) |
 |
 |
3-Pyridinol,5-(1R,4R)-2,5-diazabicyclo[2.2.1]hept-2-yl-(9CI) |
 |
 |
2,5-Diazabicyclo[2.2.1]heptane,2-(3-pyridinyl)-,(1R,4R)-(9CI) |
 |
 |
2,5-Diazabicyclo[2.2.1]heptane,2-(5-pyrimidinyl)-,(1R,4R)-(9CI) |
 |
 |
2,5-Diazabicyclo[2.2.1]heptane,2-(3-pyridazinyl)-,(1R,4R)-(9CI) |
 |
 |
2,5-Diazabicyclo[2.2.2]octane,2-(3-pyridinyl)-,(1S,4S)-(9CI) |
 |
 |
2,5-Diazabicyclo[2.2.1]heptane,2-(6-methyl-3-pyridinyl)-,(1S,4S)-(9CI) |
 |
 |
3-Pyridinol,5-(1S,4S)-2,5-diazabicyclo[2.2.1]hept-2-yl-(9CI) |
 |
 |
2-Pyridinamine,5-(1S,4S)-2,5-diazabicyclo[2.2.1]hept-2-yl-(9CI) |
 |
 |
2,5-Diazabicyclo[2.2.1]heptane,2-(5-pyrimidinyl)-,(1S,4S)-(9CI) |
 |
 |
2,5-Diazabicyclo[2.2.1]heptane,2-(3-pyridazinyl)-,(1S,4S)-(9CI) |
 |
 |
1-Aminotridecane |
 |
 |
4-CHLORO-2,5-DIFLUOROBENZENESULFONYL CHLORIDE |
 |
 |
5-Bromo-N-tert-butyl-2-thiophenesulfonamide |
 |
 |
CYCLOL CHLOROACETATE |
 |
 |
Thiireno[b]quinoxaline (7CI,8CI,9CI) |
 |
 |
1H-v-Triazolo[4,5-d]pyridazine,4-amino-7-methyl-(8CI) |
 |
 |
5(4H)-Oxazolone, 2,4-diphenyl- |
 |
 |
Cyclopentane, 1-ethenylidene-2-(2-methoxyethylidene)- (9CI) |
 |
 |
alpha-D-arabino-Hexopyranoside, methyl 4-amino-3,4,6-trideoxy-2-O-methyl- (9CI) |
 |
 |
1,2,3-Cyclopentanetriol, 4-amino-5-methyl-, (1R,2R,3R,4R,5R)- (9CI) |
 |